Pharma Industry News

Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis

Written by David Miller

As opioid scrutiny intensifies around the country, Mallinckrodt has received another subpoena seeking information about its sales of the powerful painkillers.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]